top of page
Search

Building Bridges for Children’s Blood Health: Bilu Uganda Convenes Israeli and Ugandan Experts at Mulago

4 hours ago
4 min read

On Wednesday, November 4th, 2026, the Seminar Room of the Hematology-Oncology Department at Mulago National Referral Hospital hosted a meeting about the future as much as the present. Bilu Uganda brought together leading pediatric hematology-oncology specialists from Israel and a broad group of Ugandan clinicians, researchers, and health leaders to explore a shared goal: improving the prevention and treatment of sickle cell disease (SCD) and childhood blood cancers in Uganda through lasting partnership.


Why This Conversation Matters

Sickle cell disease and childhood cancers place a heavy burden on children and families across Uganda. Clinical teams do remarkable work, often in settings where diagnostics, treatment options, and research capacity are stretched thin. No single institution can close these gaps alone. Meaningful progress comes from partnerships that connect patient care, training, and research, and that learn from the realities of care delivery on the ground.

That is the spirit in which this meeting was convened.


Who Was in the Room

The Israeli delegation brought deep expertise in pediatric hematology-oncology and molecular science.

Prof. Shai Izraeli, MD joined in person. He is Director Emeritus of the Rina Zaizov Pediatric Hematology Oncology Division at Schneider Children's Medical Center of Israel, and holds the Dora and Gregorio Shapiro Chair of Hematological Malignancies at Tel Aviv University.

Dr. Joanne Yacobovich, MD, MPH joined virtually. She is Chief of the Rina Zaizov Division of Pediatric Hematology & Oncology at Schneider Children's Medical Center, Head of the Molecular Hematology Laboratory at the Felsenstein Medical Research Center, and Chair of the Israeli Society of Pediatric Hematology & Oncology (ISPHO).

Prof. Ayal Hendel of Bar-Ilan University's Department of Genome Editing and Gene Therapy had planned to join virtually but had to cancel at the last minute. His field of genome editing and gene therapy points to exciting long-term possibilities for blood disorders, and we hope to welcome him to future conversations.

On the Ugandan side, invitations went to Dr. Miriam Adjambo, National Coordinator for Sickle Cell Disease at the Ministry of Health, the Baylor Uganda team, clinical and research teams from the host department, and Dr. Twaho, the Kiboga District Health Officer, with his team and the Kiboga SCD clinic team. Having national policy, referral-level specialists, and district-level care providers in one conversation meant that ideas for collaboration could be tested against the whole health system, from Mulago to the community clinic.

Hematology-Oncology Department at Mulago National Referral Hospital in a meeting about the future as much as the present with guests from Israel and a team representing BILU Uganda .

Starting with Honest Listening

The afternoon began with introductions and opening remarks from Dr. Shay Kirabo of Bilu Uganda, setting out the objectives of the visit. The host department then presented its activities and the therapeutic challenges of delivering care in a resource-limited setting, followed by questions from the visiting experts.

This order was deliberate. Strong partnerships begin with a clear picture of local needs, so that collaboration responds to the priorities of Ugandan patients and clinicians rather than arriving with a pre-set agenda.


Where Collaboration Could Grow

The presentations from the Israeli guests pointed to several areas where partnership could take root.

Investigator-initiated research. Prof. Izraeli spoke on the keys to investigator-initiated studies. For Ugandan teams, building the skills and confidence to design and lead their own studies is one of the most powerful ways to generate evidence that fits local realities, from SCD care in district clinics to childhood cancer outcomes at the national referral level.

Teaching and clinical exchange. Dr. Yacobovich presented teaching and clinical research opportunities at Schneider Children's Medical Center as a basis for future partnership. Training exchanges, shared learning, and joint clinical research could help strengthen the pipeline of pediatric hematology-oncology expertise in Uganda.

Molecular and laboratory science. With Israeli partners experienced in molecular hematology, there is potential to explore how laboratory capacity, diagnostics, and genetic knowledge can support earlier diagnosis and better-targeted care.

Sickle cell disease prevention and treatment. The 50-minute plenary discussion was devoted to leveraging comparative advantages to improve SCD prevention and treatment. Uganda offers a large patient population, committed clinical teams, and strong public health networks, including the Ministry of Health's national SCD coordination. Israel offers research methodology, advanced laboratory science, and experience in building specialist training. Combined, these strengths could support joint research, better screening and care pathways, and stronger links between hospital and district services.

Long-term innovation. As genome editing and gene therapy continue to advance, early relationships with leading research groups help ensure that African patients and researchers are part of the conversation as new approaches mature.

The Road Ahead

A single afternoon cannot build a partnership, but it can start one. The meeting created a shared understanding among institutions that may not have worked together before, and it opened a path toward the practical steps that follow: identifying priority research questions, exploring training and exchange opportunities, and connecting national and district-level programmes with international expertise.

Bilu Uganda will continue to serve as a convening partner in this work, helping connect Ugandan and Israeli institutions around shared goals and keeping children and families at the center of every discussion.


With Gratitude

We thank Prof. Izraeli and Dr. Yacobovich for sharing their time and expertise, the Mulago Hematology-Oncology Department for hosting, and every participant who joined in person and online. We are encouraged by the energy in the room and look forward to turning conversation into collaboration for the benefit of children across Uganda.

Bilu Uganda


 
 
 

Comments


bottom of page